Defunct Company
Total Trials
5
As Lead Sponsor
0
As Collaborator
Total Enrollment
140
NCT00037609
Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients
Phase: Phase 1/2
Role: Collaborator
Start: Jan 31, 2001
Completion: Feb 28, 2003
NCT00036075
Study Using CP-461 to Treat Advanced Prostate Cancer
Phase: Phase 2
Start: Aug 31, 2001
Completion: Dec 31, 2005
NCT00036257
Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia
Phase: Phase 1
Start: Mar 31, 2002
Completion: Apr 30, 2003
NCT00042055
CP-461 for the Treatment of Crohn's Disease
Start: Jul 31, 2002
Completion: Sep 30, 2003
NCT00060710
CP-461 in the Treatment of Patients With Advanced Melanoma
Start: Jan 31, 2003
Completion: Dec 31, 2004